Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19
Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 have?
Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 published?
Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 has 2024 year in the ScholarIQ index.
What is the open-access status of Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19?
Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 has closed oa status in the ScholarIQ index.
What is the DOI of Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19?
The DOI for Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 is on the source record.
What is the PMID of Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19?
The PMID for Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 is on the source record.
What is the OpenAlex record for Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19?
The OpenAlex for Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19 is on the source record.